Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance

Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagn...

Full description

Saved in:
Bibliographic Details
Published inDiabetology and metabolic syndrome Vol. 7; no. 1; p. 33
Main Authors Deng, Wuquan, Li, Changyan, Zhang, Yuping, Zhao, Jie, Yang, Mengliu, Tian, Mingyuan, Li, Ling, Zheng, Yanling, Chen, Bing, Yang, Gangyi
Format Journal Article
LanguageEnglish
Published London BioMed Central 10.04.2015
BioMed Central Ltd
Subjects
Online AccessGet full text
ISSN1758-5996
1758-5996
DOI10.1186/s13098-015-0029-0

Cover

Loading…
Abstract Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Methods Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. Results The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. Conclusion CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension.
AbstractList Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Methods Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. Results The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of [beta]-cell insulin secretion (HOMA-[beta]) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. Conclusion CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension. Keywords: C1q/TNF-related protein-3, Insulin resistance, Obesity, Essential hypertension
Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Methods Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. Results The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. Conclusion CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension.
Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of [beta]-cell insulin secretion (HOMA-[beta]) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension.
BACKGROUNDInsulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471).METHODSSerum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects.RESULTSThe serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels.CONCLUSIONCTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension.
Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity in various diseases. This study investigated the relationship between CTRP3 and IR as well as systemic inflammation in newly diagnosed obese and hypertensive patients (NCT02226471). Serum CTRP3 levels, anthropometric, inflammatory and metabolic parameters were measured in 180 obesity and essential hypertensive patients and in 66 normal weight, normotensive subjects. The serum CTRP3 levels in the obesity group were lower than those in the NW group; these levels were also lower in hypertensive subjects than in normotensive subjects. After adjusting for gender, systolic blood pressure (SBP) and diastolic blood pressure (DBP), a modestly linear relationship was observed between CTRP3 and waist circumference (WC) (r = -0.168, p = 0.009), waist-to-hip ratio (WHR) (r = -0.183, p = 0.004), homeostasis model assessment of IR (HOMA-IR) (r = -0.264, p = 0.000), triglycerides (TG) (r = -0.136, p = 0.034), fasting blood glucose (FBG) (r = -0.155, p = 0.016), fasting insulin (FINS) (r = -0.248, p = 0.000) and homeostasis model assessment of β-cell insulin secretion (HOMA-β) (r = -0.128, p = 0.047). Multiple stepwise regression analysis revealed that gender, DBP and HOMA-IR were independently associated with serum CTRP3 levels. CTRP3 was an independent factor affecting blood pressure and IR, and may play an important role in the pathogenesis of obesity and hypertension.
ArticleNumber 33
Audience Academic
Author Li, Changyan
Tian, Mingyuan
Chen, Bing
Zhang, Yuping
Li, Ling
Deng, Wuquan
Yang, Gangyi
Yang, Mengliu
Zhao, Jie
Zheng, Yanling
Author_xml – sequence: 1
  givenname: Wuquan
  surname: Deng
  fullname: Deng, Wuquan
  organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University
– sequence: 2
  givenname: Changyan
  surname: Li
  fullname: Li, Changyan
  organization: Department of Nephropathy, Chengdu Fifth Pepole’s Hospital
– sequence: 3
  givenname: Yuping
  surname: Zhang
  fullname: Zhang, Yuping
  organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University
– sequence: 4
  givenname: Jie
  surname: Zhao
  fullname: Zhao, Jie
  organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University
– sequence: 5
  givenname: Mengliu
  surname: Yang
  fullname: Yang, Mengliu
  organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University
– sequence: 6
  givenname: Mingyuan
  surname: Tian
  fullname: Tian, Mingyuan
  organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University
– sequence: 7
  givenname: Ling
  surname: Li
  fullname: Li, Ling
  organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University
– sequence: 8
  givenname: Yanling
  surname: Zheng
  fullname: Zheng, Yanling
  organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University
– sequence: 9
  givenname: Bing
  surname: Chen
  fullname: Chen, Bing
  organization: Department of Endocrinology, Southwest Hospital, Third Military Medical University
– sequence: 10
  givenname: Gangyi
  surname: Yang
  fullname: Yang, Gangyi
  email: dwq_cq@126.com
  organization: Department of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25878729$$D View this record in MEDLINE/PubMed
BookMark eNp9kt2K1DAYhousuD96AZ5IQJD1oLtJ0zTNibAMrgqLio7HIU2_zmRJk9kkXZl78WLNODsyI7L0ICV53qf9yHtaHDnvoCheEnxBSNtcRkKxaEtMWIlxJUr8pDghnLUlE6I52ns_Lk5jvMW44YzXz4rjirW85ZU4KX59hzCNaEbuLuefr8sAViXo0Sr4BMaVFJ3P5t--0rfIwj3YiFQA1IMOoGLGjEO-g2jSGinXo-V6BSGBi8a7Pxsb2sFCJZPDa6R92H3gp0lLtFJBjZAgROSHLIuTzcaQhTEpp-F58XRQNsKLh_Ws-HH9fj77WN58-fBpdnVTalbjVHbA25aBUoOgSmhOO8KI7rtKE9oT1igMgOueCsFa3YDoakLz9KqqGgUd0_SseLf1rqZuhF6DS0FZuQpmVGEtvTLy8MSZpVz4e1lTwXnVZMH5gyD4uwlikqOJGqxVDvwUJWl4XWGCKcno6y26UBakcYPPRr3B5RWrSVNhTutMXfyHyk8Po9G5BYPJ-weBN3uBJSibltHbKeWriIfgq_1Z_w65q0QG-BbQwccYYJDaJLXx5F8wVhIsN-WT2_LJXD65KZ_EOUn-Se7kj2WqbSZm1i0gyFs_BZdv-5HQb2217Hs
CitedBy_id crossref_primary_10_1530_REP_17_0783
crossref_primary_10_3390_diagnostics9020063
crossref_primary_10_1016_j_dsx_2018_10_004
crossref_primary_10_1186_s13098_015_0099_z
crossref_primary_10_1152_ajpregu_00212_2017
crossref_primary_10_1002_btm2_10150
crossref_primary_10_1016_j_cca_2015_11_031
crossref_primary_10_1152_ajpendo_00248_2015
crossref_primary_10_1016_j_plipres_2016_10_001
crossref_primary_10_1016_j_ceca_2017_06_009
crossref_primary_10_1016_j_tcm_2022_12_004
crossref_primary_10_1002_iub_2293
crossref_primary_10_1016_j_dsx_2019_04_047
crossref_primary_10_7717_peerj_2573
crossref_primary_10_1371_journal_pone_0168773
crossref_primary_10_1016_j_amjcard_2018_06_024
crossref_primary_10_3390_cells10082146
crossref_primary_10_3389_fimmu_2022_1002616
crossref_primary_10_3390_nu15061482
crossref_primary_10_1042_CS20180179
crossref_primary_10_1097_NNR_0000000000000319
crossref_primary_10_3390_metabo14120672
crossref_primary_10_1080_0886022X_2018_1561373
crossref_primary_10_1007_s42000_024_00592_5
crossref_primary_10_1016_j_cyto_2017_10_023
crossref_primary_10_5812_ijem_74250
crossref_primary_10_1186_s41231_021_00083_4
crossref_primary_10_1515_tjb_2022_0237
crossref_primary_10_1016_j_bbagen_2016_10_022
crossref_primary_10_1016_j_nefro_2022_02_002
crossref_primary_10_1186_s12950_018_0185_8
crossref_primary_10_1155_2020_8873152
crossref_primary_10_17826_cumj_735270
crossref_primary_10_3389_fendo_2022_873699
crossref_primary_10_1016_j_cca_2018_01_003
crossref_primary_10_29252_rbmb_9_1_71
crossref_primary_10_3390_ijms21218168
crossref_primary_10_1007_s11695_018_3306_9
crossref_primary_10_1097_HJH_0000000000003591
crossref_primary_10_14814_phy2_12735
crossref_primary_10_1186_s12872_019_1117_0
crossref_primary_10_1016_j_jcmgh_2022_12_013
crossref_primary_10_1615_CritRevImmunol_2024051292
crossref_primary_10_1002_cbin_10674
crossref_primary_10_36660_abc_20200669
crossref_primary_10_3390_ijms23179988
crossref_primary_10_1016_j_nefroe_2022_02_009
crossref_primary_10_14814_phy2_14306
crossref_primary_10_1016_j_mce_2018_04_006
crossref_primary_10_1111_eci_12709
crossref_primary_10_3390_jcm8060805
crossref_primary_10_1007_s00109_024_02426_8
crossref_primary_10_1371_journal_pone_0241813
crossref_primary_10_1016_j_lfs_2020_117913
crossref_primary_10_1161_CIRCRESAHA_115_306885
crossref_primary_10_3389_fphys_2020_570270
crossref_primary_10_5812_ijp_74250
Cites_doi 10.1007/BF00280883
10.1210/jc.2013-2227
10.1016/S0140-6736(14)60460-8
10.1186/1758-5996-6-72
10.1210/jc.2008-0253
10.2337/dc13-0178
10.1371/journal.pone.0055744
10.1016/j.beem.2013.01.004
10.1002/jcb.21190
10.1161/01.HYP.37.2.187
10.1161/01.CIR.98.14.1472
10.1161/CIRCULATIONAHA.112.099937
10.1016/j.cca.2013.02.003
10.1038/oby.2008.206
10.1186/1475-2840-13-14
10.1074/jbc.M007898200
10.1038/jhh.2011.58
10.1186/1475-2840-6-7
10.1042/BJ20082033
10.2337/diacare.27.12.2954
10.2337/diabetes.50.8.1943
10.1371/journal.pone.0112931
10.2337/db12-0217
10.1074/jbc.M110.180695
10.1016/j.tem.2011.12.003
10.1042/BJ20081240
10.1016/j.jjcc.2013.11.006
10.1017/S1368980008002802
10.1210/en.2010-0571
10.1042/CBI20090043
ContentType Journal Article
Copyright Deng et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated.
COPYRIGHT 2015 BioMed Central Ltd.
Deng et al.; licensee BioMed Central. 2015
Copyright_xml – notice: Deng et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated.
– notice: COPYRIGHT 2015 BioMed Central Ltd.
– notice: Deng et al.; licensee BioMed Central. 2015
DBID C6C
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1186/s13098-015-0029-0
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList



MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1758-5996
EndPage 33
ExternalDocumentID PMC4397726
A541620734
25878729
10_1186_s13098_015_0029_0
Genre Journal Article
GroupedDBID ---
0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
DIK
E3Z
EBD
EBLON
EBS
EJD
ESX
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
U2A
UKHRP
AAYXX
ALIPV
CITATION
-5E
-5G
-A0
-BR
2VQ
3V.
ACRMQ
ADINQ
C24
IPNFZ
NPM
RIG
PMFND
7X8
5PM
ID FETCH-LOGICAL-c540t-be7885eaaf93a9c73b151cdb2c13d156a0ee04d39958c6e9b413872a226aeb5c3
IEDL.DBID M48
ISSN 1758-5996
IngestDate Thu Aug 21 18:10:23 EDT 2025
Fri Sep 05 04:54:47 EDT 2025
Tue Jun 17 22:05:10 EDT 2025
Tue Jun 10 21:04:52 EDT 2025
Thu May 22 21:24:07 EDT 2025
Thu Jan 02 22:22:16 EST 2025
Tue Jul 01 01:26:40 EDT 2025
Thu Apr 24 23:11:15 EDT 2025
Sat Sep 06 07:29:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords C1q/TNF-related protein-3
Obesity
Essential hypertension
Insulin resistance
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-be7885eaaf93a9c73b151cdb2c13d156a0ee04d39958c6e9b413872a226aeb5c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/10.1186/s13098-015-0029-0
PMID 25878729
PQID 1674201031
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4397726
proquest_miscellaneous_1674201031
gale_infotracmisc_A541620734
gale_infotracacademiconefile_A541620734
gale_healthsolutions_A541620734
pubmed_primary_25878729
crossref_citationtrail_10_1186_s13098_015_0029_0
crossref_primary_10_1186_s13098_015_0029_0
springer_journals_10_1186_s13098_015_0029_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-04-10
PublicationDateYYYYMMDD 2015-04-10
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-04-10
  day: 10
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Diabetology and metabolic syndrome
PublicationTitleAbbrev Diabetol Metab Syndr
PublicationTitleAlternate Diabetol Metab Syndr
PublicationYear 2015
Publisher BioMed Central
BioMed Central Ltd
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
References P Primatesta (29_CR13) 2001; 37
B Wölfing (29_CR6) 2008; 16
T Maeda (29_CR16) 2001; 276
KM Choi (29_CR29) 2014; 13
K Nakamura (29_CR4) 2014; 63
DR Matthews (29_CR14) 1985; 28
A Kopp (29_CR5) 2010; 151
O Leal Vde (29_CR15) 2013; 419
T Maeda (29_CR30) 2010; 34
Z Mallat (29_CR11) 2009; 94
W Deng (29_CR25) 2014; 6
CP Wen (29_CR9) 2009; 12
RM Krauss (29_CR3) 1998; 98
M Ng (29_CR1) 2014; 384
B Ban (29_CR24) 2014; 9
HY Choi (29_CR19) 2013; 36
S Wurm (29_CR17) 2007; 6
AC Phillips (29_CR26) 2012; 26
MS Freiberg (29_CR12) 2004; 27
JM Li (29_CR27) 2007; 101
HJ Yoo (29_CR21) 2013; 8
W Yi (29_CR28) 2012; 125
KM Choi (29_CR18) 2012; 61
World Health Organization (29_CR10) 1999; 17
BK Tan (29_CR20) 2013; 98
T Shike (29_CR31) 2001; 50
M Chrostowska (29_CR2) 2013; 27
GW Wong (29_CR22) 2008; 416
KE Davis (29_CR8) 2008; 416
JM Peterson (29_CR23) 2010; 285
A Schäffler (29_CR7) 2012; 23
17171642 - J Cell Biochem. 2007 May 15;101(2):399-410
15562213 - Diabetes Care. 2004 Dec;27(12):2954-9
11071891 - J Biol Chem. 2001 Feb 2;276(5):3628-34
18854400 - J Clin Endocrinol Metab. 2009 Jan;94(1):255-60
17311679 - Cardiovasc Diabetol. 2007 Feb 20;6:7
11230269 - Hypertension. 2001 Feb;37(2):187-93
19947921 - Cell Biol Int. 2010 Jan 29;34(3):261-6
9760304 - Circulation. 1998 Oct 6;98(14):1472-6
18783346 - Biochem J. 2008 Dec 1;416(2):161-77
11473059 - Diabetes. 2001 Aug;50(8):1943-8
18990088 - Biochem J. 2008 Dec 1;416(2):e7-9
24932224 - Diabetol Metab Syndr. 2014 Jun 11;6:72
23731877 - Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):147-56
24152681 - J Clin Endocrinol Metab. 2013 Dec;98(12):E1891-900
3899825 - Diabetologia. 1985 Jul;28(7):412-9
24355497 - J Cardiol. 2014 Apr;63(4):250-9
23409033 - PLoS One. 2013;8(2):e55744
18421280 - Obesity (Silver Spring). 2008 Jul;16(7):1481-6
21654852 - J Hum Hypertens. 2012 Aug;26(8):485-92
22653084 - Circulation. 2012 Jun 26;125(25):3159-69
23780948 - Diabetes Care. 2013 Oct;36(10):3321-7
24880830 - Lancet. 2014 Aug 30;384(9945):766-81
20739398 - Endocrinology. 2010 Nov;151(11):5267-78
10067786 - J Hypertens. 1999 Feb;17(2):151-83
25409499 - PLoS One. 2014 Nov 19;9(11):e112931
22261190 - Trends Endocrinol Metab. 2012 Apr;23(4):194-204
23422739 - Clin Chim Acta. 2013 Apr 18;419:87-94
18547457 - Public Health Nutr. 2009 Apr;12(4):497-506
20952387 - J Biol Chem. 2010 Dec 17;285(51):39691-701
24417980 - Cardiovasc Diabetol. 2014 Jan 13;13:14
22837306 - Diabetes. 2012 Nov;61(11):2932-6
References_xml – volume: 28
  start-page: 412
  year: 1985
  ident: 29_CR14
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 98
  start-page: E1891
  year: 2013
  ident: 29_CR20
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-2227
– volume: 384
  start-page: 766
  year: 2014
  ident: 29_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60460-8
– volume: 6
  start-page: 72
  year: 2014
  ident: 29_CR25
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/1758-5996-6-72
– volume: 94
  start-page: 255
  year: 2009
  ident: 29_CR11
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-0253
– volume: 36
  start-page: 3321
  year: 2013
  ident: 29_CR19
  publication-title: Diabetes Care
  doi: 10.2337/dc13-0178
– volume: 8
  year: 2013
  ident: 29_CR21
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0055744
– volume: 27
  start-page: 147
  year: 2013
  ident: 29_CR2
  publication-title: Best Pract Res Clin Endocrinol Metab
  doi: 10.1016/j.beem.2013.01.004
– volume: 101
  start-page: 399
  year: 2007
  ident: 29_CR27
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.21190
– volume: 37
  start-page: 187
  year: 2001
  ident: 29_CR13
  publication-title: Hypertension
  doi: 10.1161/01.HYP.37.2.187
– volume: 98
  start-page: 1472
  year: 1998
  ident: 29_CR3
  publication-title: Circulation
  doi: 10.1161/01.CIR.98.14.1472
– volume: 125
  start-page: 3159
  year: 2012
  ident: 29_CR28
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.099937
– volume: 419
  start-page: 87
  year: 2013
  ident: 29_CR15
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2013.02.003
– volume: 16
  start-page: 1481
  year: 2008
  ident: 29_CR6
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2008.206
– volume: 13
  start-page: 14
  year: 2014
  ident: 29_CR29
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/1475-2840-13-14
– volume: 276
  start-page: 3628
  year: 2001
  ident: 29_CR16
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M007898200
– volume: 26
  start-page: 485
  year: 2012
  ident: 29_CR26
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2011.58
– volume: 6
  start-page: 7
  year: 2007
  ident: 29_CR17
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/1475-2840-6-7
– volume: 416
  start-page: e7
  year: 2008
  ident: 29_CR8
  publication-title: Biochem J
  doi: 10.1042/BJ20082033
– volume: 27
  start-page: 2954
  year: 2004
  ident: 29_CR12
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.12.2954
– volume: 50
  start-page: 1943
  year: 2001
  ident: 29_CR31
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.8.1943
– volume: 9
  start-page: e112931
  year: 2014
  ident: 29_CR24
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0112931
– volume: 61
  start-page: 2932
  year: 2012
  ident: 29_CR18
  publication-title: Diabetes
  doi: 10.2337/db12-0217
– volume: 285
  start-page: 39691
  year: 2010
  ident: 29_CR23
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.180695
– volume: 23
  start-page: 194
  year: 2012
  ident: 29_CR7
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2011.12.003
– volume: 416
  start-page: 161
  year: 2008
  ident: 29_CR22
  publication-title: Biochem J
  doi: 10.1042/BJ20081240
– volume: 63
  start-page: 250
  year: 2014
  ident: 29_CR4
  publication-title: J Cardiol
  doi: 10.1016/j.jjcc.2013.11.006
– volume: 12
  start-page: 497
  year: 2009
  ident: 29_CR9
  publication-title: Public Health Nutr
  doi: 10.1017/S1368980008002802
– volume: 151
  start-page: 5267
  year: 2010
  ident: 29_CR5
  publication-title: Endocrinology
  doi: 10.1210/en.2010-0571
– volume: 34
  start-page: 261
  year: 2010
  ident: 29_CR30
  publication-title: Cell Biol Int
  doi: 10.1042/CBI20090043
– volume: 17
  start-page: 151
  year: 1999
  ident: 29_CR10
  publication-title: J Hypertens
– reference: 24355497 - J Cardiol. 2014 Apr;63(4):250-9
– reference: 18854400 - J Clin Endocrinol Metab. 2009 Jan;94(1):255-60
– reference: 23422739 - Clin Chim Acta. 2013 Apr 18;419:87-94
– reference: 21654852 - J Hum Hypertens. 2012 Aug;26(8):485-92
– reference: 18783346 - Biochem J. 2008 Dec 1;416(2):161-77
– reference: 23409033 - PLoS One. 2013;8(2):e55744
– reference: 11230269 - Hypertension. 2001 Feb;37(2):187-93
– reference: 24932224 - Diabetol Metab Syndr. 2014 Jun 11;6:72
– reference: 18421280 - Obesity (Silver Spring). 2008 Jul;16(7):1481-6
– reference: 20739398 - Endocrinology. 2010 Nov;151(11):5267-78
– reference: 25409499 - PLoS One. 2014 Nov 19;9(11):e112931
– reference: 19947921 - Cell Biol Int. 2010 Jan 29;34(3):261-6
– reference: 18990088 - Biochem J. 2008 Dec 1;416(2):e7-9
– reference: 18547457 - Public Health Nutr. 2009 Apr;12(4):497-506
– reference: 22261190 - Trends Endocrinol Metab. 2012 Apr;23(4):194-204
– reference: 17311679 - Cardiovasc Diabetol. 2007 Feb 20;6:7
– reference: 23731877 - Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):147-56
– reference: 20952387 - J Biol Chem. 2010 Dec 17;285(51):39691-701
– reference: 22653084 - Circulation. 2012 Jun 26;125(25):3159-69
– reference: 22837306 - Diabetes. 2012 Nov;61(11):2932-6
– reference: 15562213 - Diabetes Care. 2004 Dec;27(12):2954-9
– reference: 24417980 - Cardiovasc Diabetol. 2014 Jan 13;13:14
– reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9
– reference: 11473059 - Diabetes. 2001 Aug;50(8):1943-8
– reference: 24880830 - Lancet. 2014 Aug 30;384(9945):766-81
– reference: 9760304 - Circulation. 1998 Oct 6;98(14):1472-6
– reference: 11071891 - J Biol Chem. 2001 Feb 2;276(5):3628-34
– reference: 24152681 - J Clin Endocrinol Metab. 2013 Dec;98(12):E1891-900
– reference: 10067786 - J Hypertens. 1999 Feb;17(2):151-83
– reference: 23780948 - Diabetes Care. 2013 Oct;36(10):3321-7
– reference: 17171642 - J Cell Biochem. 2007 May 15;101(2):399-410
SSID ssj0067574
Score 2.2972658
Snippet Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates...
Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin activity...
Background Insulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates...
BACKGROUNDInsulin resistance (IR) correlates closely with cardiovascular disease. C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that modulates insulin...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 33
SubjectTerms Analysis
Blood sugar
Development and progression
Diabetes
Endocrinology
Genetic aspects
Hypertension
Insulin resistance
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Metabolic Diseases
Obesity
Risk factors
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBajhbGXsXY3r12nwaC7IGrL8u0xhIUyaBklgb4JWVLWQCpvcfLQ_9If23NkOcxhG-zVOkLG5_Yd61wI-cAToUrwg0wBWmVCm5iVpraM6xwsMuDZPMcC54vL_Hwmvl1n16GOu-2z3fsrSW-pvVqX-VkL1hbLwZKM-ZwNiNP3MwjdURtnfNSbXwDAhQjXl3_cNnBAu2b4Nz-0myO5c1Hq_c_kGXkagCMddZw-II-sOySPL8LV-HNyD1q_uaXj5NfZ9HLCfI2KNdT3YVg4ltKP4-nV9_QTXWKaUEvVylLjMWMLZAtHm25EAFXO0BuITlc-t71x_gFSO_vDdwlf3lGNMz26A_BHLsUG4reYWNPSZk5DfjuFSB7RKYjVCzKbfJ2Oz1kYvcA0QLg1qy2ExplVal6lqtJFWgMy0KbmOkkNhHwqtjYWButiS-BqVYMvLAuuAMwpW2c6fUn2XOPsa0IB09h4Po-VEkYAndJ1bEWhEqOKoqySiMQ9P6QOfclxPMZS-vikzGXHQgkslMhCGUfk83bLz64px7-I3yGTZVdXulVoOcoAi3KwcCIip54CVRpO1ipUJsD7Y3OsAeXxgBJUUQ-W3_eCJHEJ89ecbTatxFoP7kdqRORVJ1jbN-dZCVaTVxEpBiK3JcAO4MMVt7jxncARTRY8j8iXXjhlMEHt3z_Im_-iPiJPuFceAR77mOytVxv7FnDYuj7xevcAP6gs6Q
  priority: 102
  providerName: Springer Nature
Title Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance
URI https://link.springer.com/article/10.1186/s13098-015-0029-0
https://www.ncbi.nlm.nih.gov/pubmed/25878729
https://www.proquest.com/docview/1674201031
https://pubmed.ncbi.nlm.nih.gov/PMC4397726
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9NAFB7WXRBfxLvRtY4gCMq4yWRyexCpZesitIhsoW_DZGbqFroTt2nB_R_-YM-ZpMGUVXwJtHOapDm372TOhZDXPBIqBz_IFKBVJrQJWW5Ky7hOwSIDnk1TLHCeTNOzmfgyT-YHZDfeqn2A9Y2hHc6Tmq1X739eXX8Ehf_gFT5PT2qww1goFiXMZ3NABH8EjinFWGwiuk0FgMa-KTM4zJxhV5J2k_PGU_Tc1L6x_sNb7WdS7m2nei81vkfutvCSDht5uE8OrHtAbk_aDfSH5BfYhu0lHUVXJ-fTMfOVLNZQ361h6VhMV5hEVFO1ttR4RFnD8tLRqhkgQJUz9AJi17XPfK-c_wKpnf3ue4ivrqnGiR_NifE1L8X24peYdlPTakHb7HcKcT5iVxC6R2Q2Pj0fnbF2MAPTAPA2rLQQOCdWqUURq0JncQm4QZuS6yg2EBCq0NpQGKyazYHnRQmeMs-4AqinbJno-DE5dJWzTwkFxGPDxSJUShgBdEqXoRWZiozKsryIAhLu-CB127Uch2espI9e8lQ2rJPAOomsk2FA3nY_-dG07PgX8UtkrmyqTjt1l8MEBIiD_RMBeeMpUAThylq1dQtw_9g6q0d53KMERdW95Vc7AZK4hNltzlbbWmIlCPcDNwLypBGo7s55koNN5UVAsp6odQTYH7y_4pYXvk84Ys2MpwF5txNKudOvvz-QZ__9d5-TO9wrjABffkwON-utfQEIbVMOyK1sng3I0afT6ddv8GmUjgb-bQccP8-jgddLOM748DfPZD2r
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zj9MwELZQVwJeEPcGFtZISFyyNnGc67GqqErZVgi60r5Zju2ylboONO0D_4Ufy4yTVKQCJF7jsRxlrm_iOQh5ySOhcvCDTAFaZUKbkOWmtIzrFCwy4Nk0xQLn2TydXIjpZXLZ1nHXXbZ7dyXpLbVX6zw9q8HaYjlYlDCfswFx-lEOYEQMyNFwOP0y7QwwQOBMtBeYf9zYc0GHhvg3T3SYJXlwVeo90PguudNCRzpseH2P3LDuPrk5ay_HH5CfoPe7azqKvp8t5mPmq1Ssob4Tw8qxmL4eLT5_it_QNSYK1VRtLDUeNdZAtnK0aoYEUOUMvYL4dOOz2yvnHyC1s199n_D1D6pxqkdzAP7KpdhC_BpTa2paLWmb4U4hlkd8CoL1kFyM3y9GE9YOX2AaQNyWlRaC48QqtSxiVegsLgEbaFNyHcUGgj4VWhsKg5WxOfC1KMEb5hlXAOeULRMdPyIDVzl7TCigGhsul6FSwgigU7oMrchUZFSW5UUUkLDjh9RtZ3IckLGWPkLJU9mwUAILJbJQhgF5u9_yrWnL8S_iU2SybCpL9yothwmgUQ42TgTkladApYaTtWprE-D9sT1Wj_KkRwnKqHvLLzpBkriEGWzOVrtaYrUH90M1AvK4Eaz9m_MkB7vJi4BkPZHbE2AP8P6KW135XuCIJzOeBuRdJ5yyNUL13z_Ik_-iPiW3JovZuTz_MP_4lNzmXpEE-O8TMthudvYZoLJt-bzVwl-bDzEs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Za9wwEBYlgdCX0qSXm7RRodALsbYsX49h2yU9soSygbwJWZKbhY2crncf8l_6Yzsj20u8tIW-WmNsPNc3nouQ1zwSKgc_yBSgVSa0CVluSsu4TsEiA55NU2xwPpumpxfiy2Vy2e05bfpq9z4l2fY04JQmtxrdmKpV8TwdNWB5sTUsSpiv34CYfVeg58NsbTruTTGA4Ux0qcw_3jZwRtsm-Y5P2q6X3Eqael80eUgedCCSnrRc3yf3rDsge2ddmvwR-QUWYH1Nx9HP0Ww6Yb5fxRrqZzLMHYvp2_Hs-3n8ji6wZKihammp8fixAbK5o3W7LoAqZ-gVRKpLX-deO38BqZ394SeGL26pxv0e7QPwpy7FYeLXWGTT0LqiXa07hagekSqI2GNyMfk0G5-ybg0D0wDnVqy0ECYnVqmqiFWhs7gElKBNyXUUGwj_VGhtKAz2yObA4aIEv5hnXAGwU7ZMdPyE7Lja2WeEAr6xYVWFSgkjgE7pMrQiU5FRWZYXUUDCnh9SdzPKcVXGQvpYJU9ly0IJLJTIQhkG5P3mlpt2QMe_iI-RybLtMd0otzxJAJdysHYiIG88Bao3PFmrrksB3h8HZQ0ojwaUoJZ6cPyqFySJR1jL5my9biT2fXC_XiMgT1vB2rw5T3KwoLwISDYQuQ0BTgMfnrj5lZ8Kjsgy42lAPvTCKTtz1Pz9gzz_L-pjsnf-cSK_fZ5-PST3udcjAY78iOyslmv7AuDZqnzpVfA3SNM0Ag
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+C1q%2FTNF-related+protein-3+levels+are+decreased+in+obesity+and+hypertension+and+are+negatively+correlated+with+parameters+of+insulin+resistance&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Deng%2C+Wuquan&rft.au=Li%2C+Changyan&rft.au=Zhang%2C+Yuping&rft.au=Zhao%2C+Jie&rft.date=2015-04-10&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=7&rft_id=info:doi/10.1186%2Fs13098-015-0029-0&rft.externalDocID=A541620734
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon